These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36435633)

  • 1. Nasal vaccines: solutions for respiratory infectious diseases.
    Nakahashi-Ouchida R; Fujihashi K; Kurashima Y; Yuki Y; Kiyono H
    Trends Mol Med; 2023 Feb; 29(2):124-140. PubMed ID: 36435633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Hum Vaccin Immunother; 2018; 14(9):2189-2193. PubMed ID: 29624474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primates.
    Yuki Y; Harada N; Sawada SI; Uchida Y; Nakahashi-Ouchida R; Mori H; Yamanoue T; Machita T; Kanazawa M; Fukumoto D; Ohba H; Miyazaki T; Akiyoshi K; Fujihashi K; Kiyono H
    Vaccine; 2023 Jul; 41(34):4941-4949. PubMed ID: 37385890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.
    Kong IG; Sato A; Yuki Y; Nochi T; Takahashi H; Sawada S; Mejima M; Kurokawa S; Okada K; Sato S; Briles DE; Kunisawa J; Inoue Y; Yamamoto M; Akiyoshi K; Kiyono H
    Infect Immun; 2013 May; 81(5):1625-34. PubMed ID: 23460513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Mucosal IgA-Mediated Protective Immunity Against Nontypeable
    Nakahashi-Ouchida R; Mori H; Yuki Y; Umemoto S; Hirano T; Uchida Y; Machita T; Yamanoue T; Sawada SI; Suzuki M; Fujihashi K; Akiyoshi K; Kurono Y; Kiyono H
    Front Immunol; 2022; 13():819859. PubMed ID: 35874779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal vaccines: wisdom from now and then.
    Kiyono H; Yuki Y; Nakahashi-Ouchida R; Fujihashi K
    Int Immunol; 2021 Nov; 33(12):767-774. PubMed ID: 34436595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.
    Nochi T; Yuki Y; Takahashi H; Sawada S; Mejima M; Kohda T; Harada N; Kong IG; Sato A; Kataoka N; Tokuhara D; Kurokawa S; Takahashi Y; Tsukada H; Kozaki S; Akiyoshi K; Kiyono H
    Nat Mater; 2010 Jul; 9(7):572-8. PubMed ID: 20562880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nasal vaccines].
    Kido H; Mizuno D; Takei T
    Nihon Rinsho; 2008 Oct; 66(10):1881-7. PubMed ID: 18939485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper respiratory tract immunity.
    Zuercher AW
    Viral Immunol; 2003; 16(3):279-89. PubMed ID: 14583144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in intranasal vaccine delivery: A promising non-invasive route of immunization.
    Kehagia E; Papakyriakopoulou P; Valsami G
    Vaccine; 2023 Jun; 41(24):3589-3603. PubMed ID: 37179163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management.
    Chavda VP; Vora LK; Pandya AK; Patravale VB
    Drug Discov Today; 2021 Nov; 26(11):2619-2636. PubMed ID: 34332100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques.
    Fukuyama Y; Yuki Y; Katakai Y; Harada N; Takahashi H; Takeda S; Mejima M; Joo S; Kurokawa S; Sawada S; Shibata H; Park EJ; Fujihashi K; Briles DE; Yasutomi Y; Tsukada H; Akiyoshi K; Kiyono H
    Mucosal Immunol; 2015 Sep; 8(5):1144-53. PubMed ID: 25669148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
    Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
    Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal induction of upper respiratory tract immunity to reovirus 1/L by combined upper and lower respiratory tract inoculation.
    Thompson AH; McRoberts JG; Crowe SR; London L; London SD
    Vaccine; 1999 Mar; 17(11-12):1404-15. PubMed ID: 10195776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
    Afkhami S; D'Agostino MR; Zhang A; Stacey HD; Marzok A; Kang A; Singh R; Bavananthasivam J; Ye G; Luo X; Wang F; Ang JC; Zganiacz A; Sankar U; Kazhdan N; Koenig JFE; Phelps A; Gameiro SF; Tang S; Jordana M; Wan Y; Mossman KL; Jeyanathan M; Gillgrass A; Medina MFC; Smaill F; Lichty BD; Miller MS; Xing Z
    Cell; 2022 Mar; 185(5):896-915.e19. PubMed ID: 35180381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mucosal immune system of the upper respiratory tract and recent progress in mucosal vaccines.
    Kurono Y
    Auris Nasus Larynx; 2022 Feb; 49(1):1-10. PubMed ID: 34304944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
    Marasini N; Kaminskas LM
    Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal formulations: promising strategy to deliver vaccines.
    Riese P; Sakthivel P; Trittel S; Guzmán CA
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in respiratory immunization: A focus on COVID-19 vaccines.
    He X; Chen X; Wang H; Du G; Sun X
    J Control Release; 2023 Mar; 355():655-674. PubMed ID: 36787821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal Immune Response in Nasal-Associated Lymphoid Tissue upon Intranasal Administration by Adjuvants.
    Takaki H; Ichimiya S; Matsumoto M; Seya T
    J Innate Immun; 2018; 10(5-6):515-521. PubMed ID: 29860261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.